GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare
GT Biopharma, Inc. EPS 2010–2020
GT Biopharma, Inc. annual/quarterly eps history and growth rate from 2015 to 2020. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- GT Biopharma, Inc. eps for the quarter ending March 31, 2020 was $0.02, a 77.78% decrease year-over-year.
- GT Biopharma, Inc. annual eps for 2017 was $8.60, a 107.17% decrease from 2016.
- GT Biopharma, Inc. annual eps for 2016 was $119.91, a 1438.28% decrease from 2015.
- GT Biopharma, Inc. annual eps for 2015 was $8.96.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
GT Biopharma, Inc. EPS — FAQ
GT Biopharma, Inc. (GTBP) eps over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GTBP's eps history?
The chart and table above show GT Biopharma, Inc.'s eps by year and by quarter, including the growth rate.